Welcome To Welox Pharma WHO-GMP | ISO 9001:2015

+91 7984303039 inquiry@weloxpharma.com
Translated into: English Spanish Portuguese French
+91 7984303039 inquiry@weloxpharma.com

Category

Show more...

Dacoplice Dacomitinib 45mg Tablet

  • Product Name : Dacoplice Dacomitinib 45mg Tablet
  • Category : Anti Cancer
  • Manufacturer Name : Pfizer
  • Trade Name : Dacoplice 45mg
  • Available Dosage : 45 mg
  • Packing : Bottle
  • Pack Insert/Leaflet : 1 Bottle/30 Tablets
  • Ingredients : Dacomitinib
  • Formulation : Tablet
  • Therapeutic use : helps treat non-small cell lung cancer
  • Production Capacity : 100000

Description:-

Introduction to Dacoplice 45mg Tablet

Dacoplice 45mg Tablet is a medication prescribed for the treatment of non-small cell lung cancer. It is designed to inhibit the growth of cancer cells within the body.


Uses of Dacoplice 45mg Tablet

Dacoplice 45mg Tablet is primarily used in the treatment of non-small cell lung cancer, working to slow down or halt the progression of the disease.


Benefits of Dacoplice 45mg Tablet

This medication offers the benefit of potentially improving symptoms and slowing the spread of non-small cell lung cancer. It is designed to be effective when taken consistently and as prescribed.


Mechanism of Action of Dacoplice 45mg Tablet

Dacoplice 45mg Tablet functions by interfering with the growth mechanisms of cancer cells, thereby impeding their ability to proliferate.